🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sustained Cord Circulation at Emergency Cesarean Section

RecruitingNAAges 37 Weeks - 42 WeeksAllRegion Skane
NCT06540222 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to evaluate if sustained cord circulation during resuscitation improves outcomes for term neonates born by emergency Cesarean section. The main question it aims to answer is: Does sustained cord circulation reduce admission rates to neonatal care? Researchers will compare resuscitation with an uncut umblical cord to standard resuscitation practices to see if it provides better outcomes. Participants (term neonates born by emergency Cesarean section) will: Receive resuscitation with either sustained cord circulation or standard care Be monitored for admission to neonatal care and other predefined health outcomes

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Singleton neonate * Born alive * Gestational age ≥37 weeks * Born by emergency cesarean section, epidural/spinal anesthesia, where the pediatric/neonatal team has been called for to attend. Exclusion Criteria: * Major congenital malformation that may affect resuscitation or outcome measures. * Major genetic disorder that may affect resuscitation or outcome measures.
💊

What it tests

  • Sustained cord (≥ 180 seconds) resuscitation
  • Routine (< 60 seconds) cord clamping
📍

Where

12 sites
Östra sjukhuset - Sahlgrenska Universitetssjukhuset
Gothenburg, Sweden
Hallands sjukhus, Halmstad
Halmstad, Sweden
Universitetssjukhuset i Linköping
Linköping, Sweden
Skånes Universitetssjukhus
Lund, Sweden
Skånes Universitetssjukhus, Malmö
Malmö, Sweden
Universitetssjukhuset Örebro
Örebro, Sweden
BB Stockholm
Stockholm, Sweden
Danderyds sjukhus
Stockholm, Sweden

…and 4 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy